Brendan Smith
Stock Analyst at TD Cowen
(1.93)
# 3,151
Out of 5,112 analysts
9
Total ratings
50%
Success rate
5.87%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVAX Novavax | Maintains: Hold | $8 → $7 | $6.53 | +7.20% | 2 | Nov 4, 2025 | |
| WST West Pharmaceutical Services | Initiates: Buy | $350 | $269.13 | +30.05% | 1 | Oct 29, 2025 | |
| SLP Simulations Plus | Initiates: Hold | $16 | $18.70 | -14.44% | 1 | Sep 30, 2025 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Buy | $3 → $10 | $8.24 | +21.36% | 1 | Sep 20, 2024 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $59 → $65 | $65.77 | -1.17% | 2 | Aug 7, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Outperform | n/a | $64.80 | - | 1 | Jul 21, 2023 | |
| DNLI Denali Therapeutics | Initiates: Outperform | n/a | $16.81 | - | 1 | Dec 5, 2022 |
Novavax
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $7
Current: $6.53
Upside: +7.20%
West Pharmaceutical Services
Oct 29, 2025
Initiates: Buy
Price Target: $350
Current: $269.13
Upside: +30.05%
Simulations Plus
Sep 30, 2025
Initiates: Hold
Price Target: $16
Current: $18.70
Upside: -14.44%
Ginkgo Bioworks Holdings
Sep 20, 2024
Maintains: Buy
Price Target: $3 → $10
Current: $8.24
Upside: +21.36%
Halozyme Therapeutics
Aug 7, 2024
Maintains: Buy
Price Target: $59 → $65
Current: $65.77
Upside: -1.17%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $64.80
Upside: -
Denali Therapeutics
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $16.81
Upside: -